<DOC>
	<DOCNO>NCT00646763</DOCNO>
	<brief_summary>The purpose study determine whether injection site cytokine , growth factor , effect peripheral blood stem cell collection .</brief_summary>
	<brief_title>A Randomized Study Site Growth Factor Injection Patients Undergoing Autologous Stem Cell Transplantation</brief_title>
	<detailed_description>The purpose study determine prefer injection site G-CSF GM-CSF , cytokine , growth factor . The doctor may also choose use growth factor combination chemotherapy increase number stem cell blood . Both option establish effective increase number stem cell blood . Patients receive one shot skin twice day approximately 12-15 day receive chemotherapy time cell collect . Patients randomly assign receive growth factor administer either abdomen extremity . Both shot always give either abdomen extremity .</detailed_description>
	<mesh_term>Lenograstim</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>All patient undergo autologous peripheral blood stem cell transplant ( PBSC ) relapsed/refractory Hodgkin 's disease , nonHodgkin 's lymphoma , patient myeloma . All patient must meet criteria transplantation . Patients active , invasive/systemic fungal infection . Patients pregnant lactating female . Patients active CNS malignant disease life expectancy limit disease disease patient transplant . Also , patient know hypersensitivity either GCSF GMCSF .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>